Innovation Medical Management Co., Ltd. (hereinafter referred to as "the Company") and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
I. Overview of the Guarantee
The Company’s wholly-owned subsidiary, Zhejiang Hongrun Pharmaceutical Co., Ltd. (hereinafter referred to as "Hongrun Pharmaceutical"), intends to apply for a loan within a credit limit of RMB 8 million from the Shaoxing Zhuji Branch of China Merchants Bank (hereinafter referred to as "China Merchants Bank Zhuji Branch") for operational needs, with a loan term of one year. The proposal to provide a guarantee for Hongrun Pharmaceutical's loan application was approved by the Company’s seventh board of directors at the second interim meeting on April 28, 2026. According to the "Shenzhen Stock Exchange Stock Listing Rules," "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 1 - Standardized Operation of Main Board Listed Companies," and other relevant laws and regulations, as well as the Company's Articles of Association, this guarantee does not require submission for shareholder meeting approval.